• 1
    Riggs BL, O'Fallon WM, Muhs J, O'Connor MK, Kumar R, Melton L Jr 1998 Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res 13: 168174.
  • 2
    Marcus R 1991 Skeletal aging. Undeerstanding the functional and structural basis of osteoporosis. Trends Endocrinol Metab 2: 5358.
  • 3
    Krolner B, Pors Nielsen S 1982 Bone mineral content of the lumbar spine in normal and osteoporotic women: Cross-sectional and longitudinal studies. Clin Sci (Lond) 62: 329336.
  • 4
    Boonen S, Aerssens J, Broos P, Pelemans W, Dequeker J 1995 Age-related bone loss and senile osteoporosis: Evidence for both secondary hyperparathyroidism and skeletal growth factor deficiency in the elderly. Aging (Milano) 7: 414422.
  • 5
    Boonen S, Lesaffre E, Aerssens J, Pelemans W, Dequeker J, Bouillon R 1996 Deficiency of the growth hormone-insulin-like growth factor-I axis potentially involved in age-related alterations in body composition. Gerontology 42: 330338.
  • 6
    Donahue L, Hunter S, Sherblom A, Rosen C 1990 Age-related changes in serum insulin-like growth factor-binding proteins in women. J Clin Endocrinol Metab 71: 575579.
  • 7
    Finkelstein JS, Roffwarg H, Boyar P, Kream J, Hellman L 1972 Age-related changes in the twenty-four hour spontaneous secretion of growth hormone in normal individuals. J Clin Endocrinol Metab 35: 665670.
  • 8
    Zadik Z, Chalew SA, Mc Carter RJ Jr, Meistas M, Kowarski AA 1985 The influence of age on the 24- hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab 60: 513516.
  • 9
    Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO 1987 Effects of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64: 5158.
  • 10
    Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR 1992 Growth hormone (GH)-releasing hormone-(1–29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab 75: 530535.
  • 11
    Vermeulen A 1987 Nyctohemeral growth hormone profiles in young and aged men: Correlation with somatomedin-C levels. J Clin Endocrinol Metab 64: 884888.
  • 12
    Iranmanesh A, Lizarralde G, Veldhuis JD 1991 Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 73: 10811088.
  • 13
    Landin-Wilhelmsen K, Wilhelmsen L, Bengtsson B 1999 Postmenopausal osteoporosis is more related to hormonal aberrations than to lifestyle factors. Clin Endocrinol (Oxf) 51: 387394.
  • 14
    Johannsson G, Rosén T, Bosaeus I, Sjöström L, Bengtsson BA 1996 Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab 81: 28652873.
  • 15
    Ahmad AM, Thomas J, Clewes A, Hopkins MT, Guzder R, Ibrahim H, Durham BH, Vora JP, Fraser WD 2003 Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism. J Clin Endocrinol Metab 88: 28602868.
  • 16
    Ahmad AM, Hopkins MT, Fraser WD, Ooi CG, Durham BH, Vora JP 2003 Parathyroid hormone secretory pattern, circulating activity, and effect on bone turnover in adult growth hormone deficiency. Bone 32: 170179.
  • 17
    Eastell R, Calvo MS, Burritt MF, Offord KP, Russell RG, Riggs BL 1992 Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis. J Clin Endocrinol Metab 74: 487494.
  • 18
    Fraser WD, Logue FC, Christie JP, Gallacher SJ, Cameron D, O'Reilly DS, Beastall GH, Boyle IT 1998 Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis. Osteoporos Int 8: 121126.
  • 19
    Cosman F, Shen V, Herrington BS 1990 Mechanism of estrogen action in osteoporosis treatment as assessed by human (1–34) PTH infusion. ChristiansenC, OvergaardK (eds.) Osteoporosis III. Osteopress, Copenhagen, Denmark, 976978.
  • 20
    Lindsay R, Sweeney A 1976 Urinary cyclic-AMP in osteoporosis. Scott Med J 21: 231.
  • 21
    Cosman F, Shen V, Herrington B, Lindsay R 1991 Response of the parathyroid gland to infusion of human parathyroid hormone-(1–34) [PTH-(1–34)]: Demonstration of suppression of endogenous secretion using immunoradiometric intact PTH-(1–84) assay. J Clin Endocrinol Metab 73: 13451351.
  • 22
    Landin-Wilhelmsen K, Nilsson A, Bosaeus I, Bengtsson B 2003 Growth hormone increases bone mineral content in postmenopausal osteoporosis: A randomized placebo-controlled trial. J Bone Miner Res 18: 393405.
  • 23
    Kassem M, Brixen K, Blum WF, Mosekilde L, Eriksen EF 1994 Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis. J Bone Miner Res 9: 13651370.
  • 24
    Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R 1994 Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J Clin Endocrinol Metab 79: 470479.
  • 25
    WHO Study Group 1994 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843: 1129.
  • 26
    Gardner MD, Dryburgh FJ, Fyffe JA, Jenkins AS 1981 Predictive value of derived calcium figures based on the measurement of ionised calcium. Ann Clin Biochem 18: 106109.
  • 27
    White TF, Farndon JR, Conceicao SC, Laker MF, Ward MK, Kerr DN 1986 Serum calcium status in health and disease: A comparison of measured and derived parameters. Clin Chim Acta 157: 199213.
  • 28
    Walton RJ, Bijvoet OL 1975 Nomogram for derivation of renal threshold phosphate concentration. Lancet 2: 309310.
  • 29
    Drezner MK, Neelon FA, Curtis HB, Lebovitz HE 1976 Renal cyclic adenosine monophosphate: An accurate index of parathyroid function. Metabolism 25: 11031112.
  • 30
    O'Reilly DS, Fraser WD, Penney MD, Logue FC, Cowan RA, Williams BC, Walters G 1986 Arginine infusion blocks the action of parathyroid hormone but not arginine vasopressin on the renal tubule in man. J Endocrinol 111: 501506.
  • 31
    Blum WF, Brier BH 1994 Radioimmunoassays for IGF's and IGFBP's. Growth Regul 4: 1119.
  • 32
    Mojon A, Fernandez JR, Hermida RC 1992 Chronolab: An interactive software package for chronobilogic time series analysis written for the Macintosh computer. Chronobiol Int 9: 403412.
  • 33
    Joseph F, Chan BY, Durham BH, Ahmad AM, Vinjamuri S, Gallagher JA, Vora JP, Fraser WD 2007 The circadian rhythm of osteoprotegerin and its association with parathyroid hormone secretion. J Clin Endocrinol Metab 92: 32303238.
  • 34
    Fernandez JR, Hermida RC 1998 Inferential statistical method for analysis of nonsinusoidal hybrid time series with unequidistant observations. Chronobiol Int 15: 191204.
  • 35
    White HD, Ahmad AM, Durham BH, Patwala A, Whittingham P, Fraser WD, Vora JP 2005 Growth hormone replacement is important for the restoration of parathyroid hormone sensitivity and improvement in bone metabolism in older adult growth hormone-deficient patients. J Clin Endocrinol Metab 90: 33713380.
  • 36
    Luboshitzky R, Shen-Orr Z, Herer P 2003 Middle-aged men secrete less testosterone at night than young healthy men. J Clin Endocrinol Metab 88: 31603166.
  • 37
    White HD, Ahmad AM, Syed AA, Clewes A, Peter R, Vora JP, Fraser WD 2004 Gender variation in PTH sensitivity and rhythmicity following growth hormone replacement in adult growth hormone-deficient patients. Clin Endocrinol (Oxf) 60: 516526.
  • 38
    Marcus R, Madvig P, Young G 1984 Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans. J Clin Endocrinol Metab 58: 223230.
  • 39
    Khosla S, Atkinson EJ, Melton L Jr, Riggs BL 1997 Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: A population-based study. J Clin Endocrinol Metab 82: 15221527.
  • 40
    Imanaka S, Onishi T, Morimoto S, Takamoto S, Kohno H, Kumahara Y 1985 Comparison of renal responses to synthetic human PTH(1–34) administration in normal young and elderly male subjects. Calcif Tissue Int 37: 357362.
  • 41
    Epstein S, Bryce G, Hinman JW, Miller ON, Riggs BL, Hui SL, Johnston CC 1986 The influence of age on bone mineral regulating hormones. Bone 7: 421425.
  • 42
    Orwoll ES, Meier DE 1986 Alterations in calcium, vitamin D and parathyroid hormone physiology in normal men with aging: Relationship to the development of senile osteoporosis. J Clin Endocrinol Metab 63: 12621269.
  • 43
    Minisola S, Pacitti MT, Scarda A, Rosso R, Romagnoli E, Carnevale V, Scarnecchia L, Mazzuoli GF 1993 Serum ionized calcium, parathyroid hormone and related variables: Effect of age and sex. Bone Miner 23: 183193.
  • 44
    Ledger GA, Burritt MF, Kao PC, O'Fallon WM, Riggs BL, Khosla S 1994 Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab 79: 211216.
  • 45
    Buchanan JR, Myers CA, Greer RB III 1988 Effect of declining renal function on bone density in aging women. Calcif Tissue Int 43: 16.
  • 46
    Lieberman S, Holloway L, Marcus R, Hoffman A 1994 Interactions of growth hormone and parathyroid hormone in renal phosphate, calcium, and calcitriol metabolism and bone remodeling in postmenopausal women. J Bone Miner Res 9: 17231728.
  • 47
    Marcus R, Butterfield G, Holloway L, Gilliland L, Baylink DJ, Hintz RL, Sherman BM 1990 Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 70: 519527.
  • 48
    Broadus AE, Mahaffey JE, Bartter FC, Neer RM 1977 Nephrogenous cyclic adenosine monophosphate as a parathyroid function test. J Clin Invest 60: 771783.
  • 49
    Logue F, Fraser W, O'Reilly D, Beastall G 1989 The circadian rhythm of intact parathyroid hormone (1–84) and nephrogenous cyclic adenosine monophosphate in normal men. J Endocrinol 121: R1R3.
  • 50
    el-Hajj Fuleihan G, Klerman EB, Brown EN, Choe Y, Brown EM, Czeisler CA 1997 The parathyroid hormone circadian rhythm is truly endogenous–a general clinical research center study. J Clin Endocrinol Metab 82: 281286.
  • 51
    Tsai KS, Heath H, Kumar R, Riggs BL 1984 Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis. J Clin Invest 73: 16681672.
  • 52
    Heshmati HM, Khosla S, Burritt MF, O'Fallon WM, Riggs BL 1998 A defect in renal calcium conservation may contribute to the pathogenesis of postmenopausal osteoporosis. J Clin Endocrinol Metab 83: 19161920.
  • 53
    Juppner H, Brown EM, Kronenberg HM 1999 Parathyroid hormone. FavusM (ed.) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA, USA, 8087.
  • 54
    Spencer EM, Tobiassen O 1981 The mechanism of the action of growth hormone on vitamin D metabolism in the rat. Endocrinology 108: 10641070.
  • 55
    Spanos E, Barrett D, MacIntyre I, Pike JW, Safilian EF, Haussler MR 1978 Effect of growth hormone on vitamin D metabolism. Nature 273: 246247.
  • 56
    Chipman JJ, Zerwekh J, Nicar M, Marks J, Pak CY 1980 Effect of growth hormone administration: Reciprocal changes in serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption. J Clin Endocrinol Metab 51: 321324.
  • 57
    Kruse K, Kracht U, Gopfert G 1982 Renal threshold phosphate concentration (TmPO4/GFR). Arch Dis Child 57: 217223.
  • 58
    Caversazio J, Bonjour JP, Fleisch H 1989 Adaptation of tubular phosphate transport: Relation between phosphate requirement as influenced by growth and supply. Adv Exp Med Biol 128: 107111.
  • 59
    Ogle GD, Rosenberg AR, Kainer G 1992 Renal effects of growth hormone. II. Electrolyte homeostasis and body composition. Paediatr Nephrol 6: 483489.
  • 60
    Bouillon R 1991 Growth hormone and bone. Horm Res 36(Suppl 1): 4955.